Cytokinetics has revealed the results from a phase 3 trial of its hypertrophic cardiomyopathy (HCM) drug aficamten that it hopes will allow it to compete with Bristol-Myers Squibb’s first-to-market ...
Results of dose-ranging study suggest potential for best-in-class clinical profile across efficacy, safety and ease of use, including simplified dosing regimen with minimal to no titration necessary ...
Anyway, since we started a little bit, it's totally on me. I'm Emily Field covering U.S. biopharma here at Barclays, and we are -- that's why I got the whole squad. So CEO, Robert Blum and... So to ...
On Wednesday, 11 March 2026, Cytokinetics Inc. (NASDAQ:CYTK) presented at the Barclays 28th Annual Global Healthcare Conference. The company highlighted its strategic focus on the global launch of ...
Aortic stenosis is 1 of the most common heart valve diseases among adults. When symptoms develop, prognosis is poor, and current guidelines recommend prompt aortic valve replacement. Depending of the ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
Introduction & Objectives Idiopathic arterial pulmonary hypertension (IPAH) is a chronic, progressive respiratory disease, characterised by elevated pulmonary artery pressure. The disease carries ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results